Skip to main content
SpringerLink
Log in

Antibacterials are an essential component in the treatment of meticillin-resistant Staphylococcus aureus (MRSA) skin infections

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III

References

  1. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: implications for patients and practitioners. Am J Clin Dermatol 2007; 8(5): 259–70

    Article  PubMed  Google Scholar 

  2. Kowalski TJ, Berbari EF, Osmon DR. Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clin Proc 2005; 80(9): 1201–8

    Article  PubMed  Google Scholar 

  3. Miller LG, Diep BA. Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008 Mar 1; 46(5): 752–60

    Article  PubMed  CAS  Google Scholar 

  4. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: a review of epidemiology, clinical features, management, and prevention. Int J Dermatol 2007; 46(1): 1–11

    Article  PubMed  CAS  Google Scholar 

  5. Cook HA, Furuya EY, Larson E, et al. Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2007 Feb 1; 44(3): 410–3

    Article  PubMed  CAS  Google Scholar 

  6. Cohen PR. The skin in the gym: a comprehensive review of the cutaneous manifestations of community-acquired methicillin-resistant Staphylococcus aureus in athletes. Clin Dermatol 2008 Jan–Feb; 26(1): 16–26

    Article  PubMed  Google Scholar 

  7. Cohen PR. Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection: a personal perspective of a world-wide epidemic. Expert Rev Dermatol 2006; 1(5): 631–7

    Article  Google Scholar 

  8. Cohen PR, Kurzrock R. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: an emerging clinical problem. J Am Acad Dermatol 2004 Feb; 50(2): 277–80

    Article  PubMed  Google Scholar 

  9. Le J, Lieberman JM. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children. Pharmacotherapy 2006 Dec; 26(12): 1758–70

    Article  PubMed  CAS  Google Scholar 

  10. Cohen PR, Grossman ME. Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections. J Am Acad Dermatol 2004 Jul; 51(1): 132–5

    Article  PubMed  Google Scholar 

  11. Ruhe JJ, Monson T, Bradsher RW, et al. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Clin Infect Dis 2005 May; 40(10): 1429–34

    Article  PubMed  CAS  Google Scholar 

  12. Carter MK, Ebers VA, Younes BK, et al. Doxycycline for community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections. Ann Pharmacotherapy 2006 Sep; 40(9): 1693–5

    Article  Google Scholar 

  13. Rybak MJ, LaPlante KL. Community-associated methicillin-resistant Staphylococcus aureus: a review. Pharmacotherapy 2005 Jan; 25(1): 74–85

    Article  PubMed  CAS  Google Scholar 

  14. Singer J, Dowler M, Bosscher B. Emergency department perspective on methicillin-resistant Staphylococcus aureus. Pediatr Emergency Care 2006 Apr; 22(4): 270–6

    Article  Google Scholar 

  15. Drew RH. Emerging options for treatment of invasive, multidrugresistant Staphylococcus aureus infections. Pharmacotherapy 2007 Feb; 27(2): 227–49

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antibacterials are an essential component in the treatment of meticillin-resistant Staphylococcus aureus (MRSA) skin infections. Drugs Ther. Perspect 24, 10–13 (2008). https://doi.org/10.2165/00042310-200824070-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200824070-00003

Search

Navigation